Long-term sexual functioning in germ-cell tumor survivors

BMC Cancer

Table 3 Subgroup univariate analysis of sexual functioning in GCT survivors treated with orchiectomy only versus with chemotherapy containing ≥400 mg/m² of cisplatin or < 400 mg/m² of cisplatin^a

		N	Mean	SEM	Median	P value
Sexual desire	AS	17	3.29	0.21	3	NA
	< 400	51	3.31	0.14	3	0.94
	≥400	80	3,05	0.09	3	0.23
		N	Mean	SEM	Median	P value
Attempts to initiate intercourse	AS	17	2.41	0.39	2	NA
	< 400	51	2.61	0.25	3	0.65
	≥400	80	2.38	0.18	2	0.91
		N	Mean	SEM	Median	P value
Achieve erection	AS	17	4.47	0.42	5	NA
	< 400	51	4.12	0.22	5	0.55
	≥400	80	3.90	0.19	5	0.17
		N	Mean	SEM	Median	P value
Maintain erection	AS	17	4.47	0.41	5	NA
	< 400	51	3.84	0.23	5	0.16
	≥400	80	3.78	0.18	4	0.06
		N	Mean	SEM	Median	P value
Achieve orgasm	AS	17	4.65	0.38	5	NA
	< 400	50	4.34	018	5	0.37
	≥400	80	3.97	0.17	5	0.03
		N	Mean	SEM	Median	P value
Disappointed with quality of sex life	AS	17	1.35	0.22	1	NA
	< 400	50	1.52	0.11	1	0.67
	≥400	79	1.65	0.10	1	0.24
		N	Mean	SEM	Median	P value
Anxiety from sexual relationships	AS	17	1.41	0.21	1	NA
	< 400	50	1.24	0.09	1	0.23
	≥400	79	1.48	0.09	1	0.97
		N	Mean	SEM	Median	P value
Strong desire to be sexually active	AS	17	2.88	0.26	3	NA
	< 400	50	2.88	0.15	3	0.98
	≥400	79	2.76	0.11	3	0.63

Abbreviations: AS Active surveillance, < 400 - chemotherapy containing < 400 mg/m2 of cisplatin,
≥400 - chemotherapy containing ≥400 mg/m2 of cisplatin, SEM – standard error of the mean, NA – not applicable
^aone patient receiving VAB VAI regimen was excluded from this analysis

ISSN: 1471-2407